Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis

Journal of the Neurological Sciences

Volumn 267, Issue 1-2, 2008, Pages 66-69

  Murata, Takahiko ^a,b   Ohtsuka, Chigumi ^b   Terayama, Yasuo ^b  

^a Iwate Prefectural Ninohe Hospital 38 Horino Aza Ookawarake Ninohe   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Cerebrospinal fluid; Coenzyme Q10; Mitochondria; Sporadic amyotrophic lateral sclerosis

Indexed keywords

UBIDECARENONE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MITOCHONDRION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; ENERGY METABOLISM; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; UBIQUINONE;

EID: 39149119244     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.09.038     Document Type: Article

References (30)

1. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222 (1999) 236-245
2. Siddique T., Figlewicz D.A., Pericak-Vance M.A., Haines J.L., Rouleau G., Jeffers A.J., et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med 324 (1991) 1381-1384
3. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
4. Ferrante R.J., Bowne S.E., Shinobu L.A., Bowling A.C., Baik M.J., MacGarvey U., et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neorochem 69 (1997) 2064-2074
5. Przedboski S., Donaldson D., Jakowec M., Kish S.J., Guttman M., Rosoklija G., et al. Brain superoxide dismutase, catalase and glutathione peroxidase activities in amyotrophic lateral sclerosis. N Engl Ann Neurol 39 (1996) 158-165
6. Bogdanov M., Brown Jr. R.H., Matson W., Smart R., Hayden D., O' Donnell H., et al. Increased oxidative damage to DNA in ALS patients. Free Radic Biol Med 29 (2000) 652-658
7. Oteiza P.I., Uchitel O.D., Carrasquedo F., Dubrovski A.L., Roma J.C., and Fraga C.G. Evaluation of antioxidants, proteins and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neorochem Res 22 (1997) 535-539
8. Bonnefont-Rousselot D., Lacomblez L., Jaudon M., Lepage S., Salachas F., Bensimon G., et al. Blood oxidative stress in amyotrophic lateral sclerosis. J Neurol Sci 178 (2000) 57-62
9. Iwasaki Y., Ikeda K., and Kinoshita M. Vitamin A and E levels are normal in amyotrophic lateral sclerosis. J Neurol Sci 29 (1995) 652-658
10. Paraskevas G.P., Kapaki E., Libitaki G., Zournas C., Segditsa I., and Papageorgiou C. Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease. Acta Neurol Scand 96 (1997) 88-90
11. Molina J.A., de Bustos F., Jimenez-Jimenez F.J., Gomez-Escalonilla C., Garcia-Redondo A., Esteban J., et al. Serum levels of coenzyme Q10 in patients with amyotrophic lateral sclerosis. J Neural Transm 107 (2000) 1021-1026
12. Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., and Isobe C. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann Neurol 46 (1999) 129-131
13. Tohgi H., Abe T., Saheki M., Yamazaki K., and Takahashi S. α-Tocopherol quinine level is remarkably low in the cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Neurosci Lett 207 (1996) 5-8
14. Yamamoto Y., Kawamura M., Tatsuno K., Niki E., and Naito C. Formation of lipid hydroperoxides in the cupric ion-induced oxidation of plasma and low density lipoprotein. In: Davies K.J.A. (Ed). Oxidative Damage and Repair (1991), Pergamon Press, New York 287-291
15. Stocker R., Browry V.W., and Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci USA 88 (1991) 1646-1650
16. Jablecki C.K., Berry, and Leach J. Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve 12 (1989) 833-841
17. Yamashita S., and Yamamoto Y. Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal Biochem 250 (1997) 66-73
18. Beal M.F., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., and Brown R.H. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 42 (1997) 644-564
19. Abe K., Pan L.H., Watanabe M., Konno H., Kato T., and Itoyama Y. Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol Res 19 (1997) 124-128
20. Yamamoto Y., Komuro E., and Niki E. Antioxidant activity of ubiquinol in solution and phosphatidylcholine liposome. J Nutri Sci Vitaminol 36 (1990) 505-511
21. Shults C.W., Haas R.H., Passov D., and Beal M.F. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neurol 42 (1997) 261-264
22. Richter C., Park J.W., and Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 85 (1988) 6465-6467
23. Mattiazzi M., D' Aurelio M., Gajewski C.D., Martushova K., Kiaei M., Beal M.F., et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem 277 (2002) 29626-29633
24. Sturtz L.A., Diekert K., Jensen L.T., Lill R., and Culotta V.C. A fraction of yeast Cu/Zn superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria: a physiological role for SOD1 in guarding against mitochondrial oxidative damage. J Biol Chem 276 (2001) 38084-38089
25. Borthwick G.M., Johnson M.A., Ince P.G., Shaw P.J., and Turnbull D.M. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol 46 (1999) 787-790
26. Bowling A.C., Schulz J.B., Brown R.H., and Beal M.F. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 61 (1993) 2322-2325
27. Kong J., and Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 18 (1998) 3241-3250
28. Jaarsma D., Rognoni F., Duijn W.V., Verspaget H.W., Haasdijk E.D., and Holstege J.C. Cu/Zn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta Neuropathol 102 (2001) 293-305
29. Beal M.F. Coenzyme Q10 as a possible treatment for neurodegenerative disease. Free Radic Res 36 (2002) 455-460
30. Sohmiya M., Tanaka M., Suzuki Y., Tanino Y., Okamoto K., and Yamamoto Y. An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients. J Neurol Sci 228 (2005) 49-53